MA53508A - Cristal de pyrazolo[3,4-d]pyrimidine - Google Patents

Cristal de pyrazolo[3,4-d]pyrimidine

Info

Publication number
MA53508A
MA53508A MA053508A MA53508A MA53508A MA 53508 A MA53508 A MA 53508A MA 053508 A MA053508 A MA 053508A MA 53508 A MA53508 A MA 53508A MA 53508 A MA53508 A MA 53508A
Authority
MA
Morocco
Prior art keywords
pyrazolo
pyrimidine
crystal
pyrimidine crystal
Prior art date
Application number
MA053508A
Other languages
English (en)
Inventor
Hiromi Oshiumi
Tadashi Shimamura
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of MA53508A publication Critical patent/MA53508A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
MA053508A 2018-08-29 2019-08-28 Cristal de pyrazolo[3,4-d]pyrimidine MA53508A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018159840 2018-08-29

Publications (1)

Publication Number Publication Date
MA53508A true MA53508A (fr) 2022-05-11

Family

ID=69644316

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053508A MA53508A (fr) 2018-08-29 2019-08-28 Cristal de pyrazolo[3,4-d]pyrimidine

Country Status (6)

Country Link
US (1) US20210332056A1 (fr)
EP (1) EP3845537A4 (fr)
JP (1) JP7282787B2 (fr)
CN (1) CN112638914A (fr)
MA (1) MA53508A (fr)
WO (1) WO2020045475A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102075886B1 (ko) 2015-09-01 2020-02-11 다이호야쿠힌고교 가부시키가이샤 신규한 피라졸로[3,4-d]피리미딘 화합물 또는 그 염

Also Published As

Publication number Publication date
EP3845537A1 (fr) 2021-07-07
JPWO2020045475A1 (ja) 2021-08-10
CN112638914A (zh) 2021-04-09
WO2020045475A1 (fr) 2020-03-05
EP3845537A4 (fr) 2022-05-11
US20210332056A1 (en) 2021-10-28
JP7282787B2 (ja) 2023-05-29

Similar Documents

Publication Publication Date Title
HK1257146A1 (zh) 新型的吡唑並[3，4-d]嘧啶化合物或其鹽
SG11202006906XA (en) Substituted 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-ones
DK3800189T3 (da) Fremstilling af (s)-n-(5-((r)-2-(2,5-difluorphenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidin-1-carboxamid
DK3419978T3 (da) Pyrazolo[1,5-A]pyrazin-4-yl-derivater som JAK-hæmmere
IL266305B (en) History of [4,2,1]triazolo[5,1-a]pyrimidine as pde2 inhibitors
DK3442975T3 (da) 1,5-dihydro-4h-pyrazolo[3,4-d]pyrimidin-4-oner og 1,5-dihydro-4h-pyrazolo[4,3-c]pyridin-4-oner som pde1-inhibitorer
DK3400225T3 (da) Pentansyrederivater substitueret med pyrrolo-[2,3-b]pyrimidinpyridiner til behandling af influenzavirusinfektioner
DK3737684T3 (da) 2,4,6,7-tetrahydro-pyrazolo[4,3-d]pyrimidin-5-on-derivater og relaterede forbindelser som c5a-receptormodulatorer til behandling af vaskulitis og inflammatoriske sygdomme
EP3096762C0 (fr) Pyrazolo[1,5-a]pyrimidines comme composés antiviraux
DK3412673T3 (da) Fremgangsmåde til fremstilling af pyrrolo[3,2-D]pyrimidin-forbindelse og mellemprodukter deraf
EP3508487A4 (fr) COMPOSÉ DE PYRAZOLO [1,5-a]PYRIMIDINE
MA46690A (fr) Composés de [1,2,4]triazolo [1,5-a]pyrimidine en tant qu'inhibiteurs de pde2
IL262711A (en) History of a [3,2,1]triazolo[5,4-d]pyrimidine with affinity for the type 2 cannabinoid receptor
DK3596080T3 (da) Farmakologisk aktive alicyclisk-substitueret pyrazolo[1,5-a]pyrimidin-derivater
DK3459953T3 (da) Hidtil ukendt 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-on-derivat
DK3362453T3 (da) Cykliske etherderivater af pyrazolo[1,5-a]pyrimidin-3-carboxyamid
ZA201703900B (en) Piperidine substituted tricyclic pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (rsv)
MA54960A (fr) Dérivé de 7h-pyrrolo [2,3-d] pyrimidine-4-amine
MA53508A (fr) Cristal de pyrazolo[3,4-d]pyrimidine
DK3511333T3 (da) Krystalform og saltform af 7h-pyrrolo[2,3-d]pyrimidinforbindelse og fremgangsmåde til fremstilling deraf
EP3590516A4 (fr) Activateur d'effet antitumoral utilisant un composé pyrazolo[3,4-d]pyrimidine
DK3816164T3 (da) Isothiazolo[5,4-d]pyrimidin-forbindelse som irak4-inhibitor
ZA201902828B (en) Crystal of pyrido[3, 4-d]pyrimidine derivative or solvate thereof
ZA201704586B (en) Pyrazolo[3,4-d]pyrimidin derivative and its use for the treatment of leishmaniasis
GB201910656D0 (en) New use of triazolo(4,5-d)Pyrimidine deerivatives